Area of research
Pulmonary and Respiratory Medicine · Oncology · imunotherapy
Research interest
Research interests include Lung Cancer Treatments and Mutations, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Lung Cancer Research Studies, and Lung Cancer Diagnosis and Treatment.
The critical role of accurate neoplastic cell percentage (NCP) assessment: investigating targeted training strategies for pulmonary biopsy and cytology specimens.
The potential clinical benefit of routine comprehensive genomic profiling in non-small cell lung cancer for the detection of prognostic co-mutations – A multicenter next generation sequencing study
Regional variations in molecular testing and treatment of patients with metastatic NSCLC in the Netherlands
Evolving treatment strategies and the impact of centralization on outcomes in thymic epithelial tumors: A nationwide population-based study from the Netherlands
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials.
HER2-low across solid tumours: different incidences and definitions
Comprehensive Analysis of Neurogenic Differentiation Factor 1 (NEUROD1), Achaete-Scute Homolog 1 (ASCL1), POU Class 2 Homeobox 3 (POU2F3), and Yes-Associated Protein 1 (YAP1) Expression Signatures Reveals Unique Large-Cell Neuroendocrine Carcinoma (LCNEC) Subgroups With Potential Therapeutic Implications.
Artificial intelligence for diagnosis and prognosis of thymic epithelial tumors: a systematic review.
Induction of cardiac fibulin-4 protects against pressure overload-induced cardiac hypertrophy and heart failure.
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC.
Deep Learning-Based Retinoblastoma Protein Subtyping of Pulmonary Large-Cell Neuroendocrine Carcinoma on Small Hematoxylin and Eosin-Stained Specimens.
Thoughts on mastocytosis in COVID-19: an author's response.
Rapid On-Site Evaluation of Cryobiopsies in Interstitial Lung Disease Using Higher Harmonic Generation Microscopy.
Assessment of Immunohistochemical PD-L1 Expression by AI Algorithms in NSCLC: The Time has Come for Validation in Prospective Clinical Trials
Thymic epithelial tumours: histopathological classification and differential diagnosis.
Increase in venous thromboembolism in SARS-CoV-2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi.
Prediction of molecular subclasses of uveal melanoma by deep learning using routine haematoxylin-eosin-stained tissue slides.
Thoracic tumour pathology.
Congenital lung malformations.
Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy.
COllaborative Neonatal Network for the first European CPAM Trial (CONNECT): a study protocol for a randomised controlled trial.
Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer.
Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers
Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?
Vascular histopathology and connective tissue ultrastructure in spontaneous coronary artery dissection: pathophysiological and clinical implications.
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis.
Lung allograft standardized histological analysis (LASHA) template: A research consensus proposal.
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic.